A novel mutation of the erythroid-specific delta-aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia
Citation
H. Harigae et al., A novel mutation of the erythroid-specific delta-aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia, AM J HEMAT, 62(2), 1999, pp. 112-114
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
AMERICAN JOURNAL OF HEMATOLOGY
SICI code
0361-8609(199910)62:2<112:ANMOTE>2.0.ZU;2-4
Abstract
A novel missense mutation, G663A, In exon 5 of the erythroid-specific delta
-aminolevulinate synthase gene (ALAS2) was identified in a Japanese male wi
th pyridoxine-responsive sideroblastic anemia. Activity of the mutant delta
-aminolevulinate synthase protein expressed in vitro was 15.1% compared wit
h the normal control, but was increased up to 34.5% by the addition of pyri
doxal 5'-phosphate, consistent with the clinical response of the patient to
pyridoxine treatment, The same mutation was also detected in genomic DNA f
rom the oral mucosal membrane of the patient; however, it was not detected
in other family members. These findings suggest that this G663A mutation is
responsible for sideroblastic anemia in the proband, and may be an index m
utation in this pedigree, Am. J. Hematol. 62:112-114, 1999. (C) 1999 Wiley-
Liss, Inc.